164 related articles for article (PubMed ID: 34022224)
21. MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis.
Kim J; Kwon H; Shin YK; Song G; Lee T; Kim Y; Jeong W; Lee U; Zhang X; Nam G; Jeung HC; Kim W; Jho EH
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13529-13540. PubMed ID: 32482852
[TBL] [Abstract][Full Text] [Related]
22. Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer.
Ando T; Charindra D; Shrestha M; Umehara H; Ogawa I; Miyauchi M; Takata T
Oncogene; 2018 Jan; 37(2):263-270. PubMed ID: 28925394
[TBL] [Abstract][Full Text] [Related]
23. The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
Mohamed A; Sun C; De Mello V; Selfe J; Missiaglia E; Shipley J; Murray GI; Zammit PS; Wackerhage H
J Pathol; 2016 Sep; 240(1):3-14. PubMed ID: 27184927
[TBL] [Abstract][Full Text] [Related]
24. Icariin stimulates osteogenic differentiation of rat bone marrow stromal stem cells by increasing TAZ expression.
Wei Q; He M; Chen M; Chen Z; Yang F; Wang H; Zhang J; He W
Biomed Pharmacother; 2017 Jul; 91():581-589. PubMed ID: 28486190
[TBL] [Abstract][Full Text] [Related]
25. TAZ is overexpressed in prostate cancers and regulates the proliferation, migration and apoptosis of prostate cancer PC3 cells.
Lin M; Bu C; He Q; Gu J; Wang H; Feng N; Jiang SW
Oncol Rep; 2020 Aug; 44(2):747-756. PubMed ID: 32468018
[TBL] [Abstract][Full Text] [Related]
26. Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage.
Tai CJ; Su TC; Jiang MC; Chen HC; Shen SC; Lee WR; Liao CF; Chen YC; Lin SH; Li LT; Shen KH; Yeh CM; Yeh KT; Lee CH; Shih HY; Chang CC
J Transl Med; 2013 Jan; 11():29. PubMed ID: 23369209
[TBL] [Abstract][Full Text] [Related]
27. CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF.
Li Y; Yuan S; Liu J; Wang Y; Zhang Y; Chen X; Si W
J Cell Physiol; 2020 Mar; 235(3):2071-2079. PubMed ID: 31347172
[TBL] [Abstract][Full Text] [Related]
28. Vinculin promotes nuclear localization of TAZ to inhibit ECM stiffness-dependent differentiation into adipocytes.
Kuroda M; Wada H; Kimura Y; Ueda K; Kioka N
J Cell Sci; 2017 Mar; 130(5):989-1002. PubMed ID: 28115535
[TBL] [Abstract][Full Text] [Related]
29. The Hippo pathway integrates PI3K-Akt signals with mechanical and polarity cues to control tissue growth.
Borreguero-Muñoz N; Fletcher GC; Aguilar-Aragon M; Elbediwy A; Vincent-Mistiaen ZI; Thompson BJ
PLoS Biol; 2019 Oct; 17(10):e3000509. PubMed ID: 31613895
[TBL] [Abstract][Full Text] [Related]
30. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
31. The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine.
Nagashima S; Bao Y; Hata Y
Curr Drug Targets; 2017; 18(4):447-454. PubMed ID: 26758663
[TBL] [Abstract][Full Text] [Related]
32. Rottlerin exhibits antitumor activity via down-regulation of TAZ in non-small cell lung cancer.
Zhao Z; Zheng N; Wang L; Hou Y; Zhou X; Wang Z
Oncotarget; 2017 Jan; 8(5):7827-7838. PubMed ID: 27999199
[TBL] [Abstract][Full Text] [Related]
33. YAP/TAZ for cancer therapy: opportunities and challenges (review).
Guo L; Teng L
Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
[TBL] [Abstract][Full Text] [Related]
34. Importin α1 Mediates Yorkie Nuclear Import via an N-terminal Non-canonical Nuclear Localization Signal.
Wang S; Lu Y; Yin MX; Wang C; Wu W; Li J; Wu W; Ge L; Hu L; Zhao Y; Zhang L
J Biol Chem; 2016 Apr; 291(15):7926-37. PubMed ID: 26887950
[TBL] [Abstract][Full Text] [Related]
35. TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation.
Matsushita A; Sato T; Mukai S; Fujishita T; Mishiro-Sato E; Okuda M; Aoki M; Hasegawa Y; Sekido Y
Oncogene; 2019 Mar; 38(11):1966-1978. PubMed ID: 30401981
[TBL] [Abstract][Full Text] [Related]
36. TAZ responds to fluid shear stress to regulate the cell cycle.
Lee HJ; Ewere A; Diaz MF; Wenzel PL
Cell Cycle; 2018; 17(2):147-153. PubMed ID: 29143545
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein.
Tanas MR; Ma S; Jadaan FO; Ng CK; Weigelt B; Reis-Filho JS; Rubin BP
Oncogene; 2016 Feb; 35(7):929-38. PubMed ID: 25961935
[TBL] [Abstract][Full Text] [Related]
38. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
[TBL] [Abstract][Full Text] [Related]
39. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J
J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317
[TBL] [Abstract][Full Text] [Related]
40. TAZ and YAP are frequently activated oncoproteins in sarcomas.
Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
